We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03711058
Brief Title: Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer

First Submitted : October 15, 2018
First Submitted that Met QC Criteria : October 15, 2018
First Posted : October 18, 2018

Last Update Submitted that Met QC Criteria : August 16, 2022
Last Update Posted : August 17, 2022